FDA — authorised 28 January 2016
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: approved
🇺🇸 Zepatier in United States
FDA authorised Zepatier on 28 January 2016
Marketing authorisation
Zepatier in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Zepatier approved in United States?
Yes. FDA authorised it on 28 January 2016.
Who is the marketing authorisation holder for Zepatier in United States?
MERCK SHARP DOHME holds the US marketing authorisation.